CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Phase II Study of Topotecan and Etoposide as Second-line Treatment in Chemotherapy-refractory Small-cell Lung Cancer
Chul Kim, Joo Hyuk Sohn, Joo Hang Kim, Se Kyu Kim, Young Sam Kim, Joon Chang, Jae Yong Cho
Cancer Research and Treatment. 2002;34(5):334-338.   Published online 2002 October 31    DOI:

Excel Download

Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide
Lung Cancer. 1994;11:126   Crossref logo
Link1 Link2

EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)
Lung Cancer. 2000;29(1):51   Crossref logo
Link1 Link2

A phase II study testing weekly platinum derivative combination chemotherapy as second-line treatment in patients with advanced small cell lung cancer
Lung Cancer. 1995;12(3):277   Crossref logo
Link1 Link2

Combined chemotherapy with etoposide, irinotecan plus cisplatin compared with topotecan monotherapy as the second-line treatment in sensitive relapsed small cell lung cancer: A retrospective analysis
Annals of Oncology. 2017;28:ii17   Crossref logo
Link1 Link2 Link3

Randomized Phase Ii Study of Belotecan or Topotecan Chemotherapy As Second-Line Chemotherapy After Platinum-Based First-Line Chemotherapy for Small Cell Lung Cancer
Annals of Oncology. 2014;25:iv515   Crossref logo
Link1 Link2 Link3

Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer
Lung Cancer. 1994;10(5-6):423   Crossref logo
Link1 Link2

P-576 Phase II trial of weekly topotecan in the second-line treatment of small cell lung cancer
Lung Cancer. 2003;41:S237   Crossref logo
Link1 Link2

A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer
Lung Cancer. 2003;39(2):215-219   Crossref logo
Link1 Link2

Combination Chemotherapy with Irinotecan and Ifosfamide as Second-Line Treatment of Refractory or Sensitive Relapsed Small Cell Lung Cancer: A Phase II Study
Chemotherapy. 2003;49(4):200-205   Crossref logo
Link1 Link2

Topotecan (T) as second-line therapy following ifosfamide-carboplatin-etoposide (ICE) and maintenance for small cell lung cancer (SCLC)
Lung Cancer. 2000;29(1):67   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.